EdgeNewswire

First Patients Enrolled at SENTA Partners in the US

  • 1 min read
  • Adherium Limited ASX: ADR

At a glance

Company
Adherium Limited
Ticker
ASX: ADR
Announcement
Partnership
Location
Atlanta, Georgia, United States

Key figures

SENTA locations
48
SENTA states
six
SENTA specialists, physician assistants and nurse practitioners
88

Products and programs

  • Hailie platform
  • Hailie sensors

November 21, 2023 -- Adherium Limited (ASX: ADR), a leading digital health company specialising in remote patient monitoring and data solutions for respiratory patients, confirms the first patients have been enrolled and remote patient monitoring underway as part of the SENTA’s commercial roll out of the Hailie® platform.

In September Adherium entered a partnership with SENTA (Southern Ear, Nose, Throat and Allergy), one of the largest, premier specialty allergy and asthma medical groups in the United States. The first patients are now being monitored and managed at SENTA clinics in Atlanta, Georgia.

Enrollment will expand and scale to more patients and providers into 2024 within SENTA’s 48 locations in six states with 88 specialist allergy, asthma and ENT physicians, physician assistants and nurse practitioners.

Hailie’s FDA 510(k) cleared advanced, drug agnostic sensors are the first to measure inhaler use and inspiratory flow rate. Adherium's state-of-the-art Hailie sensor technology and software platform empower patients and their doctors with information to improve adherence, reduce exacerbations and improve quality of life.

Hailie enables doctors to bill for long-term, remote patient management under established US reimbursement codes. Adherium is paid for sensor sales and receives monthly, per patient fees for generating and transmitting respiratory data.

If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.

Questions around this news

  1. What does the SENTA rollout of Hailie involve?

    The release says the first patients were being monitored at SENTA clinics in Atlanta, Georgia, after a partnership announced in September. It describes plans to extend enrollment to more patients and providers across SENTA’s locations into 2024. The monitoring uses sensors and software to collect respiratory data for patients and their doctors.

  2. What does FDA 510(k) clearance mean?

    510(k) clearance is a U.S. regulatory decision that allows a medical device to be marketed when it is found substantially equivalent to a legally marketed device, called a predicate. It is distinct from approval through a process that requires a different level of evidence. The specific requirements depend on the device and its intended use.

  3. What is inspiratory flow rate?

    Inspiratory flow rate is the speed at which a person draws air into their lungs during inhalation. In respiratory care, measuring it can help assess how someone breathes and whether their inhalation technique is suitable for a particular inhaler. The measurement is different from simply recording whether or when an inhaler was used.

Back to News Center
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2026   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.